PubRank

Andreas Otte

Author PubWeight™ 24.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Nuclear medicine asleep in sleep research? Eur J Nucl Med Mol Imaging 2002 1.45
2 [Neuropsychiatric involvement in systemic lupus erythematosus. Part 2: diagnostic and therapy]. Med Klin (Munich) 2003 1.40
3 Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life. Epilepsia 2004 1.12
4 Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 2002 1.11
5 Functional imaging: where is the future? Hell J Nucl Med 2005 1.06
6 Renal toxicity after radionuclide therapy. Radiat Res 2004 0.93
7 Deep-brain stimulation for Parkinson's disease. N Engl J Med 2013 0.91
8 Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150. Eur J Nucl Med Mol Imaging 2003 0.89
9 Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy. J Clin Sleep Med 2007 0.84
10 Imaging of mild traumatic brain injury using 57Co and 99mTc HMPAO SPECT as compared to other diagnostic procedures. Med Sci Monit 2003 0.82
11 Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis? Eur J Nucl Med Mol Imaging 2002 0.81
12 Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers. Eur J Nucl Med Mol Imaging 2003 0.79
13 Is radiation nephropathy caused by yttrium-90? Lancet 2002 0.77
14 Did Maurice Ravel have a whiplash syndrome? Med Sci Monit 2003 0.77
15 Soft tissue metastasis of an osteosarcoma of the humerus in a four-legged patient. Eur J Nucl Med Mol Imaging 2002 0.76
16 Functional neuroimaging endpoints in drug development. Nucl Med Commun 2005 0.76
17 90Y-Ibritumomab tiuxetan: new drug, interesting concept, and encouraging in practice. Nucl Med Commun 2006 0.76
18 Cognitive neuroactivation using SPECT and the Stroop Colored Word Test in patients with diffuse brain injury. J Neurotrauma 2004 0.76
19 The whiplash odyssey. Med Sci Monit 2003 0.75
20 Non-ionizing diagnostic evaluation of ingested foreign bodies. Dtsch Arztebl Int 2013 0.75
21 Positron emission tomography and single-photon emission tomography in neurosciences. Hell J Nucl Med 2012 0.75
22 Music and Neurophysiology. Dtsch Arztebl Int 2017 0.75
23 Functional imaging of the suicidal brain. Nucl Med Commun 2005 0.75
24 90Y-DOTATOC and nephrotoxicity. Eur J Nucl Med Mol Imaging 2002 0.75
25 Music and medical research. Med Sci Monit 2004 0.75
26 Brain SPECT in sleep research. Sleep 2003 0.75
27 The future of nuclear medicine. Hell J Nucl Med 2005 0.75
28 Inspiration-sleep-rest and nuclear medicine. Hell J Nucl Med 2006 0.75
29 Hybrid imaging: which road to go? Hell J Nucl Med 2008 0.75
30 Functional neuroimaging in whiplash injury. Eur J Pain 2012 0.75
31 [[Medico-historical findings of (neuro-) prosthetics: an online survey]. Arch Kriminol 2015 0.75
32 The rationale of a longer life span and nuclear medicine. Hell J Nucl Med 2011 0.75
33 European regulatory framework on the use and development of pharmaceuticals and radiopharmaceuticals for pediatrics. Hell J Nucl Med 2011 0.75
34 How diseases become sicker. Med Sci Monit 2002 0.75
35 Myelosuppressive side-effects of radioimmunotherapy of non-Hodgkin's lymphoma: is there an increased risk? Nucl Med Commun 2005 0.75
36 [Nicolò Paganini: Devil's violinist because of abnormal hands?--New investigations using a bronze cast from the right hand]. Arch Kriminol 2014 0.75
37 [Use of sonography in splinter injuries: a model simulation]. Arch Kriminol 2015 0.75
38 Whiplash Syndrome- a disorder of the brain? Hell J Nucl Med 2017 0.75
39 Functional neuroimaging at the 2002 APSS 16th annual meeting in Seattle. Med Sci Monit 2002 0.75
40 Neuroimaging in mild traumatic brain injury and M. Ravel's injury. Hell J Nucl Med 2012 0.75
41 The hospital organization of the future. Nucl Med Rev Cent East Eur 2004 0.75
42 The legal standards for the radioactive or non radioactive drugs research and approval in the European Community and in Germany after the thalidomide catastrophe. Hell J Nucl Med 2010 0.75
43 Practical and clinical benefits of radioimmunotherapy lead to advantages in cost-effectiveness in the treatment of patients with non-Hodgkin's lymphoma. Nucl Med Commun 2006 0.75
44 Is (90)Y-DOTATOC treatment for neuroendocrine tumours safe? Med Sci Monit 2002 0.75
45 Drug development parameters for functional imaging in neurosciences. Hell J Nucl Med 2007 0.75
46 Does health economics have an impact on non-Hodgkin's lymphoma patients' options? Nucl Med Commun 2008 0.75